Nitric oxide production during adjuvant-induced and collagen-induced arthritis

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1677-1684

  Cannon, Grant W ^a   Openshaw, Scott J ^a   Hibbs Jr , John B ^a   Hoidal, John R ^a   Huecksteadt, Thomas P ^a   Griffiths, Marie M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; HEAT SHOCK PROTEIN; MESSENGER RNA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; MYCOBACTERIUM BOVIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 0029775881     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391010     Document Type: Article

References (41)

1. Whitehouse MW: Adjuvant-induced polyarthritis in rats. In, Handbook of Animal Models for the Rheumatic Diseases. Edited by RA Greenwald, HS Diamond. Boca Raton, FL, CRC Press, 1988
2. Van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR: Arthritis induced by a T-lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A 82:5117-5120, 1985
3. Johnson WJ, Muirhead KA, Meunier PC, Votta BJ, Schmitt TC, DiMartino MJ, Hanna N: Macrophage activation in rat models of inflammation and arthritis: systemic activation precedes arthritis induction and progression. Arthritis Rheum 29:1122-1130, 1986
4. Taurog JD, Sandberg GP, Mahowald ML: The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient. Cell Immunol 75:271-282, 1983
5. Taurog JD, Sandberg GP, Mahowald ML: The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol 80:198-204, 1983
6. Pearson CM, Wood FD: Passive transfer of adjuvant arthritis by lymph node or spleen cells. J Exp Med 120:547-560, 1964
7. Cohen IR, Holoshitz J, van Eden W, Frenkel A: T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum 28:841-845, 1985
8. Stanescu R, Lider O, van Eden W, Holoshitz J, Cohen IR: Histopathology of arthritis induced in rats by active immunization to mycobacterial antigens or by systemic transfer of T lymphocyte lines: a light and electron microscopic study of the articular surface using cationized ferritin. Arthritis Rheum 30:779-792, 1987
9. Levine S, Saltzman A: Induction of arthritis in rats by aqueous suspensions of mycobacteria without the use of oil. Arthritis Rheum 34:63-67, 1991
10. Taurog JD, Kerwar SS, McReynolds RA, Sandberg GP, Leary SL, Mahowald ML: Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med 162:962-978, 1985
11. Cannon GW, Harper DS, Clayton F, Griffiths MM: Passive transfer of adjuvant-induced arthritis into irradiated DA recipient rats. Autoimmunity 15:267-274, 1993
12. Issekutz AC, Meager A, Otterness I, Issekutz TB: The role of tumor necrosis factor-alpha and IL-1 in polymorphonuclear leukocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol 97:26-32, 1994
13. Griffiths MM, Eichwald EJ, Martin JH, Smith CB, DeWitt CW: Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum 24:781-789, 1981
14. Larsson P, Kleinau S, Holmdahl R, Klareskog L: Homologous type II collagen-induced arthritis in rats: characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 33:693-701, 1990
15. Griffiths MM, Cremer MA, Harper DS, McCall S, Cannon GW: Immunogenetics of collagen-induced arthritis in rats: both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens. J Immunol 149:309-316, 1992
16. Griffiths MM, DeWitt CW: Immunogenetic control of experimental collagen-induced arthritis in rats. II. ECIA susceptibility and immune response to type II collagen (calf) are linked to RT1. J Immunogenetics 8:463-470, 1981
17. av1 haplotype. Arthritis Rheum 36:254-258, 1993
18. Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, Ogawa T, Hamaoka T, Senoh H, Fujiwara H: Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 140:1477-1484, 1988
19. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H: T Lymphocytes in collagen II-induced arthritis in mice: characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 22:295-306, 1985
20. Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS: Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum 27:1010-1017, 1984
21. Haqqi TM, Banerjii S, Jones WL, Anderson G, Behlke MA, Loh DY, Luthra HS, David CS: Identification of T-cell receptor V beta deletion mutant mouse strain AU/ssJ (H-2q) which is resistant to collagen-induced arthritis, Immunogenetics 229:180-185, 1989
22. Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, Samlowski WE: Evidence for cytokine inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867-877, 1992
23. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902, 1992
24. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASE J 6:3051-3064, 1992
25. Kosaka H, Imaizumi K, Imai K, Tyuma I: Stoichiometry of the reaction of oxyhemoglobin with nitrite. Biochim Biophys Acta 581:184-188, 1979
26. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie O, Nathan DF, Wahl SM: Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178:749-754, 1993
27. Stichtenoth DO, Gutzki FM, Tskikas D, Selve N, Bode-Boder SM, Boger RH, Frolich JC: Increased urinary nitrate excretion in rats with adjuvant arthritis. Ann Rheum Dis 53:547-549, 1994
28. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH: N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37:1062-1069, 1994
29. Oyanagui Y: Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci 54:PL285-PL289, 1994
30. Ialenti A, Moncada S, DiRosa M: Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 110:701-706, 1993
31. Cannon GW, Remmers EF, Wilder RL, Hibbs JB, Griffiths MM: Nitric oxide production during adjuvant-induced arthritis is associated with tumor necrosis factor genotype. Transplant Proc 27:1543-1544, 1995
32. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH: Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 22:1992-1998, 1995
33. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS, Currie MG: Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 273:15-24, 1995
34. G-monomethyl-L-arginine. J Exp Med 179:651-660, 1994
35. Stefanovic-Racic M, Stadler J, Evans CH: Nitric oxide and arthritis. Arthritis Rheum 36:1036-1044, 1993
36. Ueki Y, Miyake S, Tominaga Y, Eguchi K: Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230-236, 1996
37. Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, Ralston SH: Elevated nitric oxide production in rheumatoid arthritis: detection using the fasting urinary nitrate: creatinine ratio. Arthritis Rheum 39:643-647, 1996
38. Cannon GW, McCall S: Inhibition of the passive transfer of adjuvant-induced arthritis by gold sodium thiomalate. J Rheumatol 10:436-438, 1990
39. Cannon GW, Harper, DS: The effects of flurbiprofen on the passive transfer of adjuvant-induced arthritis. Agents Actions 35:64-70, 1992
40. Eden WV, Boog CJP, Hogervorst EJM, Wauben MHM: A mycobacterial 65 kD heat-shock protein and T cells in experimental arthritis: possibilities for immunotherapy. In, Monoclonal Antibodies, Cytokines, and Arthritis. Edited by TF Kresina. New York, Marcel Dekker, 1991
41. Cannon GW, Griffiths MM, Woods ML: Suppression of adjuvant-induced arthritis in DA rats by incomplete Freund's adjuvant. Arthritis Rheum 36:126-131, 1993